Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)

NCT: NCT05763407 · ACTIVE_NOT_RECRUITING

NCT IDNCT05763407
StatusACTIVE_NOT_RECRUITING
Start Date2023-06-19
Completion2027-12

Brief Summary

Early Feasibility Study of the NORM™ System in Heart Failure Patients

Frequently Asked Questions

What is Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)?

Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII) is a clinical trial registered under NCT05763407. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05763407?

The current status of NCT05763407 (Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)) is: ACTIVE_NOT_RECRUITING.

When did Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII) start?

Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII) started on 2023-06-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑